33. Infectious Complications of Immunomodulating Biologic Agents
Thursday, October 3, 2013: 10:30 AM-12:00 PM
Room: The Moscone Center: 130-131 (Hall E)
Co-organized with the Transplant Infectious Disease and Compromised Host Interest Group

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • review the mechanism of action of current immunomodulating biologic agents
  • discuss the role of biologics in the management of oncologic and hematologic malignancies including stem cell transplantation, solid organ transplantation, and autoimmune diseases
  • describe the important infectious complications associated with these novel drugs

Target Audience: pharmacists, nurses, microbiologists, members-in-training, infectious diseases physicians, infectious diseases pediatricians, hospital epidemiologists, health care workers, fellows, epidemiologists, clinicians, academicians

Tracks: Pediatric ID, Adult ID

Moderators:  Lindsey Baden, MD, FIDSA, Brigham and Women's Hospital and Kimberly Hanson, MD, MHS, University of Utah School of Medicine

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-13-082-L01-P


L. Baden, None

K. Hanson, None

S. Hammond, Merck: Investigator, Research support

S. Martin, None

L. Baden, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.